Astrana Health, Inc. (NASDAQ:ASTH) is 325 Capital LLC’s 4th Largest Position

325 Capital LLC increased its holdings in Astrana Health, Inc. (NASDAQ:ASTH) by 30.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 886,916 shares of the company’s stock after buying an additional 206,009 shares during the quarter. Astrana Health accounts for about 10.8% of 325 Capital LLC’s investment portfolio, making the stock its 4th largest position. 325 Capital LLC owned approximately 1.58% of Astrana Health worth $27,964,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Astrana Health during the 4th quarter worth $40,000. Quarry LP raised its holdings in Astrana Health by 35.5% in the 4th quarter. Quarry LP now owns 1,799 shares of the company’s stock worth $57,000 after purchasing an additional 471 shares during the period. KBC Group NV lifted its position in Astrana Health by 108.4% during the fourth quarter. KBC Group NV now owns 2,530 shares of the company’s stock valued at $80,000 after purchasing an additional 1,316 shares in the last quarter. US Bancorp DE grew its holdings in Astrana Health by 3,880.0% during the fourth quarter. US Bancorp DE now owns 4,776 shares of the company’s stock valued at $151,000 after purchasing an additional 4,656 shares during the period. Finally, Pictet Asset Management Holding SA increased its position in Astrana Health by 21.9% in the fourth quarter. Pictet Asset Management Holding SA now owns 7,075 shares of the company’s stock worth $223,000 after buying an additional 1,273 shares in the last quarter. 52.77% of the stock is currently owned by institutional investors.

Astrana Health Stock Performance

NASDAQ ASTH opened at $31.44 on Friday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. Astrana Health, Inc. has a 1-year low of $23.12 and a 1-year high of $63.20. The business has a 50 day simple moving average of $30.73 and a two-hundred day simple moving average of $37.58. The stock has a market capitalization of $1.58 billion, a PE ratio of 24.18, a P/E/G ratio of 1.37 and a beta of 1.04.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.37). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The business had revenue of $665.21 million during the quarter, compared to the consensus estimate of $617.24 million. On average, research analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on ASTH. Barclays began coverage on Astrana Health in a research note on Tuesday, April 1st. They set an “equal weight” rating and a $36.00 price objective for the company. Bank of America reduced their price objective on shares of Astrana Health from $55.00 to $49.00 and set a “buy” rating for the company in a research note on Tuesday, March 4th. Stifel Nicolaus lowered their target price on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a research note on Thursday, February 20th. Robert W. Baird decreased their price target on Astrana Health from $86.00 to $50.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd. Finally, Truist Financial dropped their price objective on Astrana Health from $50.00 to $46.00 and set a “buy” rating for the company in a research note on Tuesday, March 18th. Three analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $53.29.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.